2005
DOI: 10.1016/j.bbrc.2005.10.108
|View full text |Cite
|
Sign up to set email alerts
|

Simvastatin induces impairment in skeletal muscle while heart is protected

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
76
1
3

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 105 publications
(91 citation statements)
references
References 31 publications
11
76
1
3
Order By: Relevance
“…14,17,104 Current reports suggest that the SLC16 family of transporters, responsible for lactic acid transport across plasma membrane into muscle, also interacts with statins. 105,106 Inhibition of SLC16A4, which is primarily expressed in skeletal but not cardiac myocytes, paralleling the site of clinical myopathy, is reported to attenuate statin-induced myopathy in vitro. 106,107 This may be a good candidate gene for statin toxicity studies.…”
Section: Genetic Influences On Statinmediated Adverse Drug Reactionsmentioning
confidence: 99%
“…14,17,104 Current reports suggest that the SLC16 family of transporters, responsible for lactic acid transport across plasma membrane into muscle, also interacts with statins. 105,106 Inhibition of SLC16A4, which is primarily expressed in skeletal but not cardiac myocytes, paralleling the site of clinical myopathy, is reported to attenuate statin-induced myopathy in vitro. 106,107 This may be a good candidate gene for statin toxicity studies.…”
Section: Genetic Influences On Statinmediated Adverse Drug Reactionsmentioning
confidence: 99%
“…The histological and physiological changes induced by simvastatin might be of multifactorial etiology. Previous researches [30,31] reported mitochondrial impairment and alteration of Ca2+ homeostasis specifically in skeletal muscle due to preferential uptake of statins by monocarboxylate transporter (MCT4). In addition, statininduced skeletal myopathy might be due to depletion of the isoprenoid pool by statins (HMG-CoA reductase inhibitors) with subsequent generalized insufficient protein modification inducing myopathy [32] .…”
Section: Discussionmentioning
confidence: 99%
“…23 Moßhammer et al reported that it is not clear whether MCT4-mediated transport of statins across membranes of myocytes plays a role in myopathy. 24 We found that statin-induced cytotoxicity was associated with intracellular accumulation of statins.…”
Section: Discussionmentioning
confidence: 99%